Results 1 to 10 of about 275,528 (160)

Development and Structures of Trialogue for Bipolar Disorders in Germany and Guidelines of the German Society for Bipolar Disorders

open access: yesMedicina, 2021
The German concept of a trialogue in medicine is at its best a cooperation between patients, relatives, and professionals as partners on equal footing.
Martin Schaefer   +4 more
doaj   +1 more source

Serum BDNF levels and state anxiety are associated with somatic symptoms in patients with panic disorder

open access: yesFrontiers in Psychiatry, 2023
BackgroundWe aimed to explore the predictive role of serum BDNF and anxiety-related variables in changes in somatic symptoms post-escitalopram treatment in panic disorder (PD) patients.MethodsNinety PD patients and 99 healthy controls (HCs) were enrolled.
Jiaxin Li   +5 more
doaj   +1 more source

A pilot trial of quetiapine, lithium, or placebo added to divalproex sodium for hypomanic or manic episodes in ambulatory adults with bipolar I disorder

open access: yesInternational Journal of Bipolar Disorders, 2022
Background Many patients with bipolar I disorder do not respond to monotherapy treatment with mood-stabilizing medications, and combination regimens are commonly used in both inpatient and outpatient settings for the acute and maintenance treatment of ...
Victoria E. Cosgrove   +5 more
doaj   +1 more source

Mindfulness, Attention, and Impulsivity in Bipolar Disorder

open access: yesEuropean Psychiatry, 2023
Introduction Bipolar disorder (BD) is a chronic mental disorder characterized by mood instability1. BD is further related to neurocognitive and functional disruptions that remain remarkably stable even when patients are euthymic, leading to poor well ...
N. E. Fares-Otero   +6 more
doaj   +1 more source

Diagnostic Stability of Primary Psychotic Disorders in a Research Sample

open access: yesFrontiers in Psychiatry, 2021
Psychiatric diagnosis is often treated as a stable construct both clinically and in research; however, some evidence suggests that diagnostic change may be common, which may impact research validity and clinical care.
Andrea J. Wood   +7 more
doaj   +1 more source

Awaiting accurate scientific evidence: Progression or “profiles” in bipolar disorder?

open access: yesInternational Journal of Bipolar Disorders, 2017
This letter is written in response to a review recently published in the journal. The aim is to highlight a potential methodological limitation common to many studies comparing bipolar patients with few previous episodes versus those with multiple ...
Diego J. Martino   +2 more
doaj   +1 more source

A psychiatrist's perspective from a COVID-19 epicentre: a personal account

open access: yesBJPsych Open, 2020
BackgroundThe COVID-19 pandemic has and will have a huge impact on mental health, especially in countries that have been significantly affected, such as Spain.AimsHere we aim to provide the perspectives of a group of psychiatrists from Barcelona, one of ...
Isabella Pacchiarotti   +4 more
doaj   +1 more source

Aggression among 216 patients with a first-psychotic episode of bipolar I disorder

open access: yesInternational Journal of Bipolar Disorders, 2018
Background Aggression by patients with bipolar I disorder (BD-I) is not uncommon. Identifying potential risk factors early in the illness-course should inform clinical management and reduce risk.
Hari-Mandir K. Khalsa   +3 more
doaj   +1 more source

Trastornos afectivos y salud física, implicaciones de la comorbilidad con enfermedades médicas: una revisión de la literatura

open access: yesRevista Médica Clínica Las Condes, 2020
Resumen: Introducción: La comorbilidad médica en pacientes con trastornos del estado de ánimo tiende a convertirse en un problema de salud pública clínica y global cada vez más importante.
Lluc Colomer   +3 more
doaj   +1 more source

Existing and emerging pharmacological approaches to the treatment of mania: A critical overview

open access: yesTranslational Psychiatry, 2022
Manic episodes are a defining, frequent and dramatically disabling occurrence in the course of Bipolar Disorder type I. Current pharmacotherapy of mania lists a good number of agents, but differences in efficacy and safety profiles among these agents ...
Giulio Sparacino   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy